
Cancer hospital chain HealthCare Global Enterprises (HCG) nearly tripled its net profit to Rs 16.5 crore in the June quarter from about Rs 6 crore a year ago, the Times of India…
Cancer hospital chain HealthCare Global Enterprises (HCG) nearly tripled its net profit to Rs 16.5 crore in the June quarter from about Rs 6 crore a year ago, the Times of India reports. Total income rose 14% year-on-year to Rs 707 crore, driven by an 11% increase in patient volumes and a 2% growth in average revenue per patient.
Growth was strongest in eastern India at 22%, followed by the south at 16%. HCG added 121 operational beds during the quarter, including 56 beds at its new North Bengaluru hospital, which recorded over 550 new patient registrations and 300 admissions in its first few weeks. The company plans to add around 1,000 beds by FY30, with 60% from expanding existing hospitals.
A 200% profit jump on a 14% revenue rise suggests HCG is either controlling costs well or squeezing more out of each patient. The claim that 16 of 25 centres hit record quarterly revenue sounds impressive, but investors should ask how much of that comes from higher prices versus genuine volume growth. Average revenue per patient rose just 2%, hinting at the latter. The real test: can the planned 1,000-bed expansion maintain occupancy rates above 70% without diluting margins? That number will settle whether this is a trend or a one-time blip.
Source: timesofindia.indiatimes.com
This story was synthesised by AI from the source linked above.